ArticleBMC cancer2022

Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea.

Kyu-Tae Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.